BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care
Phase 3
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-11-09
- Last Posted Date
- 2010-12-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 204
- Registration Number
- NCT01010100
Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Diagnostic Imaging
- Interventions
- Drug: F-18 DPA-714 (BAY85-8102)
- First Posted Date
- 2009-11-06
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 22
- Registration Number
- NCT01009359
Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease
Phase 1
Completed
- Conditions
- Stenotic Femoro-popliteal ArteriesAtherosclerosisPeripheral Arterial DiseaseOccluded Femoro-popliteal Arteries
- Interventions
- Device: Paclitaxel-coated balloon catheter angioplasty
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT01007578
- Locations
- 🇩🇪
Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany
Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 63
- Registration Number
- NCT01005719
A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)
- First Posted Date
- 2009-10-30
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bayer
- Target Recruit Count
- 69
- Registration Number
- NCT01004445
Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT01003015
Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED)
Phase 3
Completed
- Conditions
- Sun Protection
- Interventions
- Drug: Standard SPF 4 Sunscreen
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 10
- Registration Number
- NCT01001975
The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib
Phase 1
Completed
- Conditions
- Dietary FatsPharmacokinetics
- Interventions
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2013-05-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT01002378
Regulatory Post Marketing Surveillance Study on YAZ
Completed
- Conditions
- ContraceptionPremenstrual SyndromeAcne
- Interventions
- Drug: EE20/DRSP (YAZ, BAY86-5300)
- First Posted Date
- 2009-10-20
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 770
- Registration Number
- NCT00998257
Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers
Phase 2
Terminated
- Conditions
- Venous Ulcer
- Interventions
- Device: Silica Gel FiberDevice: Standard-of-Care
- First Posted Date
- 2009-10-20
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 121
- Registration Number
- NCT00998673